Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07056283 · ClinicalTrials.gov registry record
The Study of Urinary Biomarkers in Patients With Hypomagnesemia
A clinical trial of Hypomagnesemia, sponsored by University of Florida.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT07056283: Recruiting study of Hypomagnesemia, sponsored by University of Florida.
NCT07056283 is a study of Hypomagnesemia that is actively recruiting participants, run by University of Florida. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07056283, a study of Hypomagnesemia, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
In this pilot exploratory study, we aim to examine extracellular vesicles (EVs) as biomarkers in urine from up to 15 patients, with up to 10 samples per patient among the patients with a history of hypomagnesemia.
Conditions Studied
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2027-06 |
What NCT07056283 shows while recruiting
NCT07056283 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 1 condition, with Hypomagnesemia appearing as the primary indexed condition, and to 0 interventions.
NCT07056283 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07056283 about?
NCT07056283 is a clinical study titled "The Study of Urinary Biomarkers in Patients With Hypomagnesemia". In this pilot exploratory study, we aim to examine extracellular vesicles (EVs) as biomarkers in urine from up to 15 patients, with up to 10 samples per patient among the patients with a history of hypomagnesemia.
What is the current status of trial NCT07056283?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2025-07-31. Estimated completion is 2027-06.
What conditions does trial NCT07056283 study?
This clinical trial studies the following conditions: Hypomagnesemia.
Who is sponsoring clinical trial NCT07056283?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07056283 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypomagnesemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI